These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates. Fine DL; Roberts BA; Terpening SJ; Mott J; Vasconcelos D; House RV Vaccine; 2008 Jun; 26(27-28):3497-506. PubMed ID: 18508163 [TBL] [Abstract][Full Text] [Related]
8. Role for mucosal immune responses and cell-mediated immune functions in protection from airborne challenge with Venezuelan equine encephalitis virus. Elvin SJ; Bennett AM; Phillpotts RJ J Med Virol; 2002 Jul; 67(3):384-93. PubMed ID: 12116032 [TBL] [Abstract][Full Text] [Related]
9. [The duration of humoral postvaccinal and postinfection immunity to the Venezuelan equine encephalomyelitis virus]. Lukin EP; Chernikova NK Vopr Virusol; 1993; 38(2):71-4. PubMed ID: 8059525 [TBL] [Abstract][Full Text] [Related]
10. Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate. Charles PC; Brown KW; Davis NL; Hart MK; Johnston RE Virology; 1997 Feb; 228(2):153-60. PubMed ID: 9123821 [TBL] [Abstract][Full Text] [Related]
11. Protection of hamsters by Venezuelan equine encephalitis virus candidate vaccine V3526 against lethal challenge by mosquito bite and intraperitoneal injection. Turell MJ; Parker MD Am J Trop Med Hyg; 2008 Feb; 78(2):328-32. PubMed ID: 18256440 [TBL] [Abstract][Full Text] [Related]
12. Intranasal immunisation with defective adenovirus serotype 5 expressing the Venezuelan equine encephalitis virus E2 glycoprotein protects against airborne challenge with virulent virus. Phillpotts RJ; O'brien L; Appleton RE; Carr S; Bennett A Vaccine; 2005 Feb; 23(13):1615-23. PubMed ID: 15694514 [TBL] [Abstract][Full Text] [Related]
14. [The immunity generated in white rats vaccinated with strains of the Venezuelan equine encephalomyelitis virus]. Moshkov SP; Grabareva LP; Moshkov AE; Gaĭdamovich SIa Vopr Virusol; 1991; 36(5):417-9. PubMed ID: 1803778 [TBL] [Abstract][Full Text] [Related]
15. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729 [TBL] [Abstract][Full Text] [Related]
16. Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB/c, but not C3H/HeN mice. Hart MK; Pratt W; Panelo F; Tammariello R; Dertzbaugh M Vaccine; 1997 Mar; 15(4):363-9. PubMed ID: 9141206 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of neurovirulence and biodistribution of Venezuelan equine encephalitis replicon particles expressing herpes simplex virus type 2 glycoprotein D. Kowalski J; Adkins K; Gangolli S; Ren J; Arendt H; DeStefano J; Obregon J; Tummolo D; Natuk RJ; Brown TP; Parks CL; Udem SA; Long D Vaccine; 2007 Mar; 25(12):2296-305. PubMed ID: 17239997 [TBL] [Abstract][Full Text] [Related]
18. [An experimental evaluation of the attenuated strain 15 of the Venezuelan equine encephalomyelitis virus]. Lukin EP; Selivanenko GM; Chernikova NK; Pshenichnov VA Vopr Virusol; 1991; 36(3):243-5. PubMed ID: 1891883 [No Abstract] [Full Text] [Related]
19. IRES-driven expression of the capsid protein of the Venezuelan equine encephalitis virus TC-83 vaccine strain increases its attenuation and safety. Guerbois M; Volkova E; Forrester NL; Rossi SL; Frolov I; Weaver SC PLoS Negl Trop Dis; 2013; 7(5):e2197. PubMed ID: 23675542 [TBL] [Abstract][Full Text] [Related]
20. Protective efficacies of live attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters. Jahrling PB; Stephenson EH J Clin Microbiol; 1984 Mar; 19(3):429-31. PubMed ID: 6715512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]